World Health Organization (WHO)

Last Updated 27 May 2022.

11 Vaccines Granted Emergency Use Listing (EUL) by WHO

• Serum Institute of India
  COVOVAX (Novavax formulation)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 5 countries

  3 trials in 1 country

  Approval Source: extranet.who.int

  Protein Subunit

• Novavax
  Nuvaxovid

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 37 countries

  16 trials in 12 countries

  Approval Source: extranet.who.int

  Protein Subunit

• Moderna
  Spikevax

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 86 countries

  63 trials in 22 countries

  Approval Source: extranet.who.int

  RNA

• Pfizer/BioNTech
  Comirnaty

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 146 countries

  80 trials in 26 countries

  Approval Source: extranet.who.int

  RNA

• CanSino
  Convidecia

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 10 countries

  13 trials in 6 countries

  Approval Source: extranet.who.int

  Non Replicating Viral Vector

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 111 countries

  23 trials in 23 countries

  Approval Source: extranet.who.int

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  Vaxzevria

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 140 countries

  63 trials in 30 countries

  Approval Source: extranet.who.int

  Non Replicating Viral Vector

• Serum Institute of India
  Covishield (Oxford/ AstraZeneca formulation)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 49 countries

  4 trials in 1 country

  Approval Source: extranet.who.int

  Non Replicating Viral Vector

• Bharat Biotech
  Covaxin

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 14 countries

  14 trials in 2 countries

  Approval Source: extranet.who.int

  Inactivated

• Sinopharm (Beijing)
  Covilo

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 91 countries

  29 trials in 12 countries

  Approval Source: extranet.who.int

  Inactivated

• Sinovac
  CoronaVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 56 countries

  37 trials in 9 countries

  Approval Source: extranet.who.int

  Inactivated